Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

205
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
205
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors01:28

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

199
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
199
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

15
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
15
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

497
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
497
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

582
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
582
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

223
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
223

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

International Outcomes of the Boston Type I Keratoprosthesis in Stevens-Johnson Syndrome.

Cornea·2015
Same author

Insights triggered by textual micro-counseling dialogues of restructuring orientation in experts and students.

PsyCh journal·2015
Same author

Water-enhanced Removal of Ciprofloxacin from Water by Porous Graphene Hydrogel.

Scientific reports·2015
Same author

Development of Small-molecule HIV Entry Inhibitors Specifically Targeting gp120 or gp41.

Current topics in medicinal chemistry·2015
Same author

Synthesis and biological evaluation of ring A and/or C expansion and opening echinocystic acid derivatives for anti-HCV entry inhibitors.

European journal of medicinal chemistry·2015
Same author

Visual Acuity, Contrast Sensitivity and Color Vision Three Years After Iodine-125 Brachytherapy for Choroidal and Ciliary Body Melanoma.

The open ophthalmology journal·2015

相关实验视频

Updated: Jul 27, 2025

Orienteering as a Tool for Cognitive Research: An Implementation Guide
07:13

Orienteering as a Tool for Cognitive Research: An Implementation Guide

Published on: November 29, 2024

837

异素改善了H的作用.

Tiehan Cui1,2, Yun Lan3, Yuying Lu3

  • 1Department of Oral and Maxillofacial Surgery, The First Affiliated Hospital of Nanchang University, Nanchang 330006, China.

Aging
|June 5, 2023
PubMed
概括

异素 (ISO) 保护红细胞免受氧化应激,这是骨关节炎的关键因素. 这种天然化合物减少了亡并增强了细胞功能,为OA治疗提供了潜力.

关键词:
在RNA-seqqq.灭症 (apoptosis) 是一种死亡的过程.生物信息学是一种生物信息学.一个东方的异国情调.氧化应激是一种氧化应激.

更多相关视频

Screening and Isolation of C-Glycoside-Cleaving Intestinal Bacteria
06:38

Screening and Isolation of C-Glycoside-Cleaving Intestinal Bacteria

Published on: February 28, 2025

402
Oxygen-Induced Retinopathy Model for Ischemic Retinal Diseases in Rodents
09:28

Oxygen-Induced Retinopathy Model for Ischemic Retinal Diseases in Rodents

Published on: September 16, 2020

8.6K

相关实验视频

Last Updated: Jul 27, 2025

Orienteering as a Tool for Cognitive Research: An Implementation Guide
07:13

Orienteering as a Tool for Cognitive Research: An Implementation Guide

Published on: November 29, 2024

837
Screening and Isolation of C-Glycoside-Cleaving Intestinal Bacteria
06:38

Screening and Isolation of C-Glycoside-Cleaving Intestinal Bacteria

Published on: February 28, 2025

402
Oxygen-Induced Retinopathy Model for Ischemic Retinal Diseases in Rodents
09:28

Oxygen-Induced Retinopathy Model for Ischemic Retinal Diseases in Rodents

Published on: September 16, 2020

8.6K

科学领域:

  • 生物化学 生物化学
  • 细胞生物学 细胞生物学
  • 药理学 药理学是指药理学的学科.

背景情况:

  • 骨关节炎 (OA) 是一种退行性关节疾病,没有有效的治疗方法.
  • 异素 (ISO) 是一种具有抗氧化特性的植物提取物,显示出对OA治疗的潜力.
  • 在OA模型中对ISO保护机制的研究是有限的.

研究的目的:

  • 为了研究ISO对H2O2诱导的红细胞的保护作用,一个体外OA模型.
  • 阐明ISO行动背后的分子机制.
  • 建立ISO在OA治疗中的使用理论基础.

主要方法:

  • RNA测序 (RNA-seq) 和生物信息学分析.
  • 细胞测试测量了亡,线粒体膜潜力 (MMP) 和活性氧物种 (ROS).
  • 对抗氧化酶 (SOD,HO-1,NQO-1) 和脂质过氧化 (MDA) 的生物化学分析.

主要成果:

  • ISO显著增强了对抗H2O2诱导的损伤的冠状细胞活性.
  • 通过抑制MAPK信号传递,ISO减少了亡并恢复了MMP.
  • 通过Nrf2和PI3K/Akt通路,ISO增加了抗氧化酶水平 (SOD,HO-1,NQO-1),降低了MDA,并通过Nrf2和PI3K/Akt通路抑制了ROS.

结论:

  • 国际标准组织表明,它有显著的保护作用,可以防止氧化应激和软质细胞的亡.
  • ISO的机制包括调节MAPK,Nrf2和PI3K/Akt信号通路.
  • 作为治疗骨关节炎的治疗药物,ISO显示出有前途,需要进一步调查.